Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 7/20 | 0.49 |
| ▸ | GAA | P10253 | 10/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | NQO1 | P15559 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28351931 | 0.89 | ELANE (0.46) | ELANEGAAKDM4EMAPTHSD17B10 | |
| SCHEMBL1401009 | 0.82 | ELANE (0.44) | ELANEGAAKDM4EMAPTHSD17B10 | |
| SCHEMBL11230576 | 0.82 | ELANE (0.44) | ELANEGAAKDM4EMAPTHSD17B10 | |
| SCHEMBL27715978 | 0.82 | SMN1; SMN2 (0.41) | ELANEKDM4EMAPTALDH1A1POLB | |
| SCHEMBL21645801 | 0.78 | GAA (0.62) | GAAKDM4EMAPTHSD17B10ALDH1A1 | |
| SCHEMBL4867725 | 0.78 | ELANE (0.47) | ELANEKDM4EMAPTHSD17B10ALDH1A1 | |
| SCHEMBL4274245 | 0.75 | KDM4E (0.39) | GAAKDM4EMAPTHSD17B10ALDH1A1 | |
| SCHEMBL11230582 | 0.72 | KDM4E (0.37) | ELANEGAAKDM4EMAPTHSD17B10 | |
| SCHEMBL5613862 | 0.72 | NQO1 (0.40) | ELANEALDH1A1NQO1 | |
| SCHEMBL15068613 | 0.71 | ELANE (0.39) | ELANEGAAKDM4EMAPTHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210299285-A1 | COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2021-09-30 | — | — | US | claimed |
| WO-2020018613-A1 | COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2020-01-23 | — | — | WO | claimed |
| CN-107206109-A | For in vitro and in vivo detection bacterium and/or the fluorescence multi-branched probe of fungi | 爱丁堡大学董事会 | 2017-09-26 | — | — | CN | claimed |
| CN-107106707-A | The molecular probe of gramnegative bacterium is detected in vitro and in vivo | 爱丁堡大学董事会 | 2017-08-29 | — | — | CN | claimed |
| CN-107109399-A | Visualizing modified nucleotide and nucleic acid interactions in a single cell | 西格马-奥尔德里奇有限责任公司 | 2017-08-29 | — | — | CN | claimed |
| US-4312855-A | FOR IMPROVING DEPOSITION OR RETENTION OF ACTIVE MATERIAL; HAIR CONDITIONERS, DETERGENTS | COLGATE-PALMOLIVE COMPANY (US) | 1982-01-26 | — | — | US | claimed |
| US-20210299285-A1 | COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2021-09-30 | — | — | US | disclosed |
| WO-2020018613-A1 | COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2020-01-23 | — | — | WO | disclosed |
| CN-103995437-B | Negative-type photosensitive silicone composition | AZ电子材料（卢森堡）有限公司 | 2019-11-29 | — | — | CN | disclosed |
| CN-110337497-A | Pass through multi-wad join labeled oligonucleotide probe | 德国癌症研究公共权益基金会 | 2019-10-15 | — | — | CN | disclosed |
| CN-110325212-A | The farnesyl transferase inhibitor of method for treating cancer | 库拉肿瘤学公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-110325912-A | Photosensitive resin composition, method for producing cured pattern, cured product, interlayer insulating film, cover coat, surface protective film, and electronic component | 日立化成杜邦微系统股份有限公司 | 2019-10-11 | — | — | CN | disclosed |
| CN-110234600-A | Molecule nano label | 美国政府(由卫生和人类服务部的部长所代表) | 2019-09-13 | — | — | CN | disclosed |
| CN-1154708-C | Chemical-ray sensitive polymer composition | 东丽株式会社 | 2004-06-23 | — | — | CN | disclosed |
| CN-1480491-A | Light sensitivity resin precursor compsn. | ������������ʽ���� | 2004-03-10 | — | — | CN | disclosed |
| CN-1405325-A | RNA probe preparation method, Target nucleic acid detection method and RNA probe preparation kit | RIKAGAKU KENKYUSHO (JP) | 2003-03-26 | — | — | CN | disclosed |
| CN-1222187-A | Mid-chain branched surfactants | PROCTER & GAMBLE (US) | 1999-07-07 | — | — | CN | disclosed |
| CN-1201061-A | Chemical-ray sensitive polymer composition | TORAY CO LTD (JP) | 1998-12-09 | — | — | CN | disclosed |
| EP-0543990-A1 | PHOTOLITHOGRAPHICALLY PATTERNED FLUORESCENT COATING | EASTMAN KODAK COMPANY (US) | 1993-06-02 | — | — | EP | disclosed |
| WO-1992022855-A1 | PHOTOLITHOGRAPHICALLY PATTERNED FLUORESCENT COATING | EASTMAN KODAK COMPANY (US) | 1992-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210299285-A1 | COMPOUNDS USEFUL FOR IN VIVO IMAGING OF PROTEIN OXIDATION AND/OR CANCER TREATMENT | QSOX1, GPX4, SDHA | ELANE 1391/4885GAA 2437/4885KDM4E 3379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.